General information.
All the solvents and reagents for the syntheses were at least reagent grade quality and were used without further purification. Anhydrous N,N-dimethylformamide was purchased from ACROS Organics. Reactions were magnetically stirred and monitored by thin layer chromatography using Fluka Silica gel or Aluminium oxide on TLC-PET foils with fluorescent indicator at 254 nm. All reactions involving ruthenium (II) were carried out in the dark. C18 reversed phase silica gel (230−400 mesh) was used for chromatography. 1 ii) Similarly to the previously reported method [1] , the linear peptide 8a was then dissolved in DMF (0.5 mM) and the pH values were adjusted to 8-9 by addition of DIPEA. PyBOP (1.3 equiv.) was added and the solution was stirred at room temperature for 1 h. Solvent was removed under reduced pressure and the residue was dissolved in a minimum of DCM. Diethyl ether was added to precipitate the cyclopeptide that was then triturated and washed three times with diethyl ether. The protected cyclopeptide was used in the next step without further purification.
iii) The protecting groups of the cyclopeptide were removed using a TFA/H2O/TIS (95:2.5:2.5) solution. After 1 h of reaction, the reaction mixture was concentrated under vacuum providing an oily residue. Pure compound 8 was obtained as a white powder after purification using preparative RP-HPLC (117 mg, 0.17 mmol, 66% yield over 3 steps).
MS (ESI+)
: m/z calculated for C32H45N9O8: 683.8, found 683.5.
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Figure S14: UPLC analysis of compound 8. 
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Molecular modelling simulations of conjugate 9. 
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Quenching studies on conjugate 7.
Luminescence quenching studies were performed on conjugate 7 in the presence of the free cyclic pentapeptide units c- As depicted in Figure S17 , the presence of the free cyclic pentapeptide units c-[RGDfK] 8 does not have a significative influence on the luminescence intensity of the intermediate 7.
Determination of the luminescence lifetime in the same conditions, i.e. for 7 alone in MeCN under air (625 ns) and for 7 in the presence of 0.5 and 1.0 mM of c-[RGDfK] 8 (644 and 692 ns respectively), confirms that no quenching is taking place between the ruthenium complex and RGD peptidic units.
In conclusion, we can safely assert that no internal quenching process is taking place in conjugate 9 and that the photophysical and photochemical properties of the ruthenium complex anchored on the calixarene platform are conserved.
